Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shunsaku Hayai"'
Autor:
Tomoya Baba, Takayasu Ito, Yoshiki Sato, Shunsaku Hayai, Junji Koyama, Shota Nakamura, Yoshiyuki Tokuda, Toyofumi Fengshi Chen‐Yoshikawa, Makoto Ishii
Publikováno v:
Respirology Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract Massive haemoptysis is a life‐threatening condition whose cause needs to be identified rapidly so that prompt interventions can ensue. Bronchial occlusion with endobronchial Watanabe spigots (EWSs) may be useful when endovascular treatment
Externí odkaz:
https://doaj.org/article/dcbd4d98839147958e60be1273517958
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Currently, immune checkpoint inhibitors (ICIs) are widely considered the standard initial treatment for advanced non-small cell lung cancer (NSCLC) when there are no targetable driver oncogenic alternations. NSCLC tumors that have two alterations in
Externí odkaz:
https://doaj.org/article/8a6f383838d34ee8a6af0909a119949d
Autor:
Shinichi Miyazaki, Yasumasa Kuno, Shunsaku Hayai, Ryo Teramachi, Ryo Yamashita, Yusuke Saito, Kosuke Higuchi, Yoshiharu Nara, Takuya Ikeda
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-5 (2020)
Abstract Background Osimertinib, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor, is selective for both epidermal growth factor receptor tyrosine kinase inhibitor–sensitizing and T790M resistance mutations. Almost all
Externí odkaz:
https://doaj.org/article/878b2f324ce146f09d495bcd09cad81d
Autor:
Kim Deoksu, Shunsaku Hayai, Junji Koyama, Reiko Matsuzawa, Keiko Wakahara, Ichidai Tanaka, Naozumi Hashimoto, Tetsunari Hase, Masahiro Morise, Yutaro Tamiya, Yoshie Shimoyama
Publikováno v:
Internal Medicine. 61:703-708
Amelanotic melanoma is a rare type of melanoma that shows little or no melanin pigmentation. When tumor lesions are not detected in cutaneous sites, the presence of melanin is the hallmark sign of malignant melanoma. We herein report a case of amelan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42ffde0db2e9f77603cf285b16b4c254
https://doi.org/10.2169/internalmedicine.6657-20
https://doi.org/10.2169/internalmedicine.6657-20
Autor:
Kazuhiro Asada, Joe Shindoh, Kazuyoshi Imaizumi, Masato Karayama, Akihito Kubo, Yuko Oya, Kenta Murotani, Eiji Kunii, Takafumi Suda, Sayako Morikawa, Tatsuya Yoshida, Toyoaki Hida, Takeshi Tsuda, Kentaro Ito, Kosuke Takahashi, Teppei Yamagichi, Tomoki Kimura, Shunsaku Hayai, Osamu Hataji, Hirokazu Taniguchi, Takashi Abe, Naoki Inui, Motoyasu Okuno
Publikováno v:
Cancer Science
We constructed a data set of EGFR‐mutant non–small‐cell lung carcinoma (NSCLC) patients, and compared the overall survival of first‐generation (1G), and second‐generation (2G) EGFR‐tyrosine kinase inhibitors (TKIs) in clinical practice us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3f6b8ef65ab0e70fb41e422a48d2e9
https://doi.org/10.1111/cas.14560
https://doi.org/10.1111/cas.14560
Autor:
Reiko, Matsuzawa, Masahiro, Morise, Ichidai, Tanaka, Shunsaku, Hayai, Yutaro, Tamiya, Junji, Koyama, Tetsunari, Hase, Keiko, Wakahara, Deoksu, Kim, Yoshie, Shimoyama, Naozumi, Hashimoto
Publikováno v:
Internal medicine (Tokyo, Japan). 61(5)
Amelanotic melanoma is a rare type of melanoma that shows little or no melanin pigmentation. When tumor lesions are not detected in cutaneous sites, the presence of melanin is the hallmark sign of malignant melanoma. We herein report a case of amelan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::926fe88bcdcbf905e4807c61b67ea861
https://pubmed.ncbi.nlm.nih.gov/34433708
https://pubmed.ncbi.nlm.nih.gov/34433708
Autor:
Reiko Matsuzawa, Masahiro Morise, Ichidai Tanaka, Shunsaku Hayai, Yutaro Tamiya, Junji Koyama, Tetsunari Hase, Keiko Wakahara, Deoksu Kim, Yoshie Shimoyama, Naozumi Hashimoto
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 5, p703-708, 6p